01 Paduaexpand_more
Padua has a strong oncology research presence, with many trials focused on breast cancer, lung cancer, colorectal cancer, ovarian cancer, and melanoma. The studies are largely aimed at testing new treatments, comparing them with current standards, and improving outcomes for advanced or hard-to-treat disease.
Breast cancer, including hormone receptor-positive, HER2-negative, HER2-positive, and triple-negative disease
Non-small cell lung cancer and small cell lung cancer, especially advanced or metastatic cases
Colorectal cancer, gastric cancer, biliary tract cancer, and other solid tumors
Melanoma, urothelial cancer, prostate cancer, and other difficult-to-treat cancers
Much of the work in Padua centers on finding more effective options for patients whose cancer has returned, spread, or stopped responding to standard care.
Hematology and Blood Disorders
A major share of the clinical research landscape involves hematologic malignancies and other blood disorders. Trials in this area are testing new therapies and combinations for both newly diagnosed and relapsed disease.
Leukemia, including acute myeloid leukemia, acute lymphoblastic leukemia, and chronic myeloid leukemia
Lymphoma, such as diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma
Multiple myeloma and related plasma cell disorders
Anemia, hemophilia, and sickle cell disease
These studies often aim to improve disease control, reduce relapse, and expand treatment choices for patients with limited options.
Cardiovascular disease is another important field in Padua, with research addressing prevention, diagnosis, and treatment of heart and vascular conditions. Several trials also focus on reducing long-term risk in high-risk patients.
Atherosclerotic cardiovascular disease and coronary artery disease
Heart failure, including systolic dysfunction and HFpEF
Myocardial infarction, atrial fibrillation, and venous thromboembolism
Calcific aortic valve stenosis and related structural heart conditions
The goal is often to lower major cardiovascular events and improve everyday clinical management.
Gastroenterology and Liver Diseases
Trials in gastroenterology and hepatology are studying inflammatory, metabolic, and advanced liver conditions. Many are designed to relieve symptoms, slow progression, or test new treatment approaches for chronic digestive disease.
Crohn’s disease, ulcerative colitis, and coeliac disease
Primary biliary cholangitis, primary sclerosing cholangitis, and cholestatic pruritus
Cirrhosis, acute-on-chronic liver failure, and hepatocellular carcinoma
Pancreatic, esophageal, and other digestive cancers
Research in this area also includes efforts to improve symptom control and quality of life for patients with chronic digestive disorders.
Pulmonology and Respiratory Disease
Respiratory medicine is well represented, with studies spanning chronic airway disease, fibrotic lung disease, and lung cancer. The focus is often on better symptom control, slowing progression, and evaluating new therapies.
Asthma, COPD, and chronic bronchiectasis
Idiopathic pulmonary fibrosis and other interstitial lung diseases
Respiratory infections and severe inflammatory lung conditions
Lung cancer, including early-stage, locally advanced, and metastatic disease
Several trials in Padua also explore whether new treatments can improve breathing, reduce flare-ups, or extend survival.
Neurology and Movement Disorders
Clinical trials in neurology cover both degenerative and rare neurological conditions. This research aims to improve symptom control, slow disease worsening, and support better long-term function.
Parkinson’s disease and related movement disorders
Amyotrophic lateral sclerosis and multiple system atrophy
Glioblastoma, glioma, and other brain tumors
Migraine, multiple sclerosis, and other neurological conditions
The local research environment supports studies of both common neurological disorders and highly specialized rare diseases.
Immunology, Autoimmune, and Inflammatory Diseases
A broad group of trials addresses immune-mediated and autoimmune diseases. These studies often test ways to calm harmful inflammation and improve disease control in chronic conditions.
Systemic lupus erythematosus, rheumatoid arthritis, and systemic sclerosis
Psoriasis, atopic dermatitis, and urticaria
Vasculitis, angioedema, and other immune disorders
Inflammatory bowel disease and other chronic inflammatory conditions
Many of these trials are designed to improve day-to-day symptom burden while also reducing longer-term complications.
Kidney and Urologic Research
Kidney and urologic trials in Padua include both chronic disease management and cancer-related studies. Researchers are also investigating transplant-related outcomes and protection of kidney function.
Chronic kidney disease, end-stage kidney disease, and IgA nephropathy
Kidney transplant rejection and delayed graft function
Bladder cancer and urothelial carcinoma
Renal cell carcinoma and other renal tumors
The overall aim is to improve kidney preservation, transplant success, and treatment options for urinary tract cancers.
Endocrinology, Metabolism, and Nutrition
Trials in endocrinology and metabolic disease cover both common chronic illnesses and rare inherited disorders. Many studies focus on improving metabolic control, reducing complications, and supporting healthier long-term outcomes.
Diabetes, obesity, and metabolic dysfunction-associated steatotic liver disease
Phenylketonuria and other inborn metabolic conditions
Cushing’s disease and congenital adrenal hyperplasia
Thyroid and other hormonal disorders
This research often combines symptom improvement with broader efforts to reduce disease-related complications.
Ophthalmology and Eye Health
Eye disease research includes studies of vision-threatening and chronic ocular conditions across children and adults. The main purpose is to improve treatment options and preserve visual function.
Myopia in children and adolescents
Glaucoma and neurotrophic keratopathy
Age-related macular degeneration and geographic atrophy
Corneal disorders and other ocular surface conditions
These studies reflect a strong interest in both early intervention and long-term eye care.
Pediatrics and Rare Diseases
The city also supports a wide range of pediatric and rare disease trials. These projects often focus on conditions with limited treatment options and aim to improve survival, function, or symptom control.
Rare genetic diseases such as Pompe disease, Niemann-Pick disease, and Prader-Willi syndrome
Muscular dystrophy and other inherited neuromuscular disorders
Rare pediatric cancers, including neuroblastoma and medulloblastoma
Congenital and neonatal conditions
Much of this work in Padua is aimed at bringing new treatment possibilities to patients with uncommon and serious illnesses.
Infectious disease research covers both prevention and treatment, including serious hospital-based infections and virus-related illnesses. The emphasis is on better protection, faster recovery, and improved clinical management.
HIV and hepatitis B
Respiratory syncytial virus, monkeypox, and herpes zoster prevention
Sepsis and bacteremia
Urinary tract and other complicated infections
Several trials are aimed at reducing infection risk in vulnerable groups and improving outcomes in acute care settings.
Surgery, Wounds, and Acute Care
A smaller but important group of trials looks at surgical and acute care needs. These studies are focused on recovery, wound healing, and safer treatment in urgent or high-risk situations.
Burns and deep skin defects
Wound closure and scar reduction
Urgent surgery in patients needing anticoagulation reversal
Acute respiratory and critical illness conditions
The research here supports better healing and more effective management of complex acute cases.
Site Activity and Trial Network
With a large number of recruiting studies, Padua stands out as an active clinical research center in Italy. Its network of sites and investigators supports broad participation across many disease areas, from common chronic illness to highly specialized rare conditions.
764 currently recruiting trials
29 research sites
239 investigators
Extensive coverage across oncology, cardiology, neurology, and rare disease research
The overall profile suggests a diverse and highly active trial environment, with strong momentum across multiple therapeutic fields.
Italy
